Delivery Order SPE2DB20D1100-SPE2DB25FD6D2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a contract value of $5,372.64. The award, issued on July 24, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial...
- The Defense Logistics Agency awarded a delivery order valued at $22,857.87 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The medication is an...
- The Defense Logistics Agency awarded a $8,058.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was fulfilled from the company's place of performance in Conshohocken, Pennsylvania,...
- This $11,684.52 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,384,970 units of Atovaquone-Proguanil 250-100 100S, a prescription anti-malarial medication. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical, which provides a comprehensive range of medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the medication Atovaquone-Proguanil 250-100 in quantities of 100 tablets, with a firm fixed price of $1,642.01 and a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- The Defense Logistics Agency Troop Support Medical awarded a $1,597.89 delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to supply 250-100mg tablets of atovaquone-proguanil packaged in lots of 100. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract has a period of performance from July 21, 2023 through July 24, 2023 and utilizes a firm fixed price contract type. As the Defense Logistics Agency is...
- The Defense Logistics Agency awarded a $25,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Atovaquone-Proguanil tablets. Under this contract, Amerisourcebergen will deliver 250-100mg units of the antimalarial drug to a location in Conshohocken, Pennsylvania by September 25, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing DLA-wide contract vehicle. The prime contractor,...
- The Defense Logistics Agency awarded a $11,857.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 250-100 count packages of atovaquone-proguanil, an antimalarial medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania between September 5-6, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order without the use of major subcontractors. As the DLA supports procurement for the...
- This is a $1,871.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria treatment medication. The delivery order has a completion date of July 11, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,912,417 units of Atovaquone-Proguanil 250-100mg tablets. The contract has a firm-fixed price of $4,079.80 and a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6D2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units, with a ceiling value of $1,343.16. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99 million through December 2026. AmerisourceBergen serves as a critical pharmaceutical prime vendor for federal medical supply needs, providing a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. The Atovaquone-Proguanil antimalarial medication supplied under this order supports the Defense Health Agency and other federal healthcare systems requiring malaria prophylaxis and treatment capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/24/25 |